Search results
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
Zacks via Yahoo Finance· 2 days agoToday's Research Daily features new research reports on 16 major stocks, including Microsoft Corp., ...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan...
Benzinga· 2 hours agoThe Structure Therapeutics GPCR stock has been identified as a potential winner in the obesity drug...
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Zacks· 5 days agoEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
Top Research Reports for Microsoft, Eli Lilly & Costco
Zacks via Yahoo Finance· 4 days agoToday's Research Daily features new research reports on 16 major stocks, including Microsoft...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks· 7 days agoThe medical spa coaxed customers into believing that its compounded tirzepatide products have...
Lilly(Eli) & Co [LLY] Shares Fall
Knox Daily· 5 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lilly(Eli< ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 14 hours agoAnalyst Hardik Parikh initiated research coverage on the clinical stage drug developer with an...
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
Investopedia· 2 days agoEli Lilly (LLY) and Ozempic and Wegovy from Danish drugmaker Novo Nordisk (NVO). The rising...
The Ozempic Diet: Nestle Launches $5 Pizza For Weight Loss Drug Users
Benzinga via Yahoo Finance· 9 hours agoThis comes amid fears among investors that food companies could see their sales suffer...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune (NASDAQ:ALT), Amgen...
Benzinga· 4 days agoIt was only after a couple of years that the market gained a second entrant – Eli Lilly's LLY...
